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The VAPB-PTPIP51 endoplasmic reticulum-
mitochondria tethering proteins are present
in neuronal synapses and regulate synaptic
activity
Patricia Gómez-Suaga1, Beatriz G. Pérez-Nievas1, Elizabeth B. Glennon1, Dawn H. W. Lau1, Sebastien Paillusson1,
Gábor M. Mórotz1, Tito Calì2, Paola Pizzo2, Wendy Noble1 and Christopher C. J. Miller1*
Abstract
Signaling between the endoplasmic reticulum (ER) and mitochondria regulates a number of key neuronal functions.
This signaling involves close physical contacts between the two organelles that are mediated by “tethering proteins”
that function to recruit regions of ER to the mitochondrial surface. The ER protein, vesicle-associated membrane
protein-associated protein B (VAPB) and the mitochondrial membrane protein, protein tyrosine phosphatase interacting
protein-51 (PTPIP51), interact to form one such tether. Recently, damage to ER-mitochondria signaling involving
disruption of the VAPB-PTPIP51 tethers has been linked to the pathogenic process in Parkinson’s disease, fronto-
temporal dementia (FTD) and related amyotrophic lateral sclerosis (ALS). Loss of neuronal synaptic function is a key
feature of Parkinson’s disease and FTD/ALS but the roles that ER-mitochondria signaling and the VAPB-PTPIP51 tethers
play in synaptic function are not known. Here, we demonstrate that the VAPB-PTPIP51 tethers regulate synaptic activity.
VAPB and PTPIP51 localise and form contacts at synapses, and stimulating neuronal activity increases ER-mitochondria
contacts and the VAPB-PTPIP51 interaction. Moreover, siRNA loss of VAPB or PTPIP51 perturbs synaptic function and
dendritic spine morphology. Our results reveal a new role for the VAPB-PTPIP51 tethers in neurons and suggest that
damage to ER-mitochondria signaling contributes to synaptic dysfunction in Parkinson’s disease and FTD/ALS.
Keywords: VAPB, PTPIP51, Endoplasmic reticulum, Mitochondria, Parkinson’s disease, Frontotemporal dementia,
Amyotrophic lateral sclerosis, Synapse
Introduction
Signaling between the ER and mitochondria regulates a var-
iety of fundamental cellular processes. These include energy
metabolism, Ca2+ homeostasis, phospholipid synthesis,
mitochondrial biogenesis and trafficking, ER stress re-
sponses, autophagy and inflammation [7, 34, 37, 39]. This
signaling is facilitated by close physical contacts between
the two organelles such that up to approximately 20% of
the mitochondrial surface is closely apposed (10–30 nm
distances) to ER membranes. These regions of ER are
termed mitochondria associated ER membranes (MAM) [7,
34, 37, 39].
The mechanisms by which ER membranes are recruited
to the mitochondrial surface are not fully understood but
it is widely agreed that the process involves “tethering pro-
teins” which act to scaffold and anchor the two organelles
in close proximity. One such tether involves an interaction
between the integral ER protein, vesicle-associated mem-
brane protein-associated protein B (VAPB) and the outer
mitochondrial membrane protein, protein tyrosine phos-
phatase interacting protein-51 (PTPIP51) [9, 45]. The
VAPB-PTPIP51 tethers are now known to facilitate inosi-
tol 1,4,5-trisphosphate (IP3) receptor mediated delivery of
Ca2+ from ER stores to mitochondria, mitochondrial ATP
production and autophagy, all of which are known to be
regulated by ER-mitochondria crosstalk [9, 13, 33, 45, 46].
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The pivotal roles that ER-mitochondria signaling plays in
so many important physiological functions suggest that dam-
age to this signaling will have detrimental effects on cellular
homeostasis. Indeed, perturbation of ER-mitochondria con-
tacts and signaling is associated with the major human
neurodegenerative diseases Alzheimer’s disease, Parkinson’s
disease and FTD/ALS [1, 23, 24, 34]. Notably, disruption to
the VAPB-PTPIP51 tethers has been linked to Parkinson’s
disease and FTD/ALS [9, 33, 45, 46]. FTD is the second
most common form of presenile dementia after Alzheimer’s
disease and is now known to be clinically, genetically and
pathologically linked to ALS, the most common form of
motor neuron disease [24, 28].
Loss of synaptic function is a key pathogenic feature of
Parkinson’s disease and FTD/ALS. Indeed, synaptic loss
underlies the cognitive and motor dysfunctions that
characterise these disorders [3, 17, 43]. Both ER and
mitochondria are known to be present in synaptic
regions [16, 18, 31, 50]. However, any role of the
VAPB-PTPIP51 tethers and ER-mitochondria signaling
in synaptic function is currently unknown. Such know-
ledge is essential not only for comprehending the nor-
mal roles of ER-mitochondria signaling in synaptic
function, but also for determining any pathological role
that disruption to the VAPB-PTPIP51 tethers might play
in Parkinson’s disease and FTD/ALS. Here, we show that
VAPB and PTPIP51 are present and interact in synaptic
regions, that their interactions are stimulated by neur-
onal activity, and that loss of VAPB and PTPIP51
disrupts synaptic function.
Materials and methods
Plasmids and siRNAs
SPLICSs and SypHy-RGECO reporter plasmids were as de-
scribed [6, 20]; pEGFPC1 was from Clontech. Verified
non-targeting control and rat VAPB and PTPIP51 siRNAs
were purchased from GE Healthcare Dharmacon (Accell
range). Sequences were: VAPB A-091473-17# 5′-GUGC
UGUUCUUUAUUGUUG-3′, A-091473-18# 5′- CUUA
UGGAUUCAAAACUUA-3′, A-091473-19# 5′-GGUUCA
GUCUAUGUUUGCU-3′, A-091473-20# 5′-GUUACAGC
CUUUCGAUUAU-3′; PTPIP51 (Fam82a2) A-092062-13#
5′-CCUUUAAUGUCAUACCUUA-3′, A-092062-14# 5′-G
CUUUAGCUUCAAGGAACA-3′, A-092062-15# 5′- GCU
ACAGCCUUGUUUGAAA-3′, A-092062-16# 5′- CUCU
GGACCUUGAUAUGGA-3′.
Antibodies and chemicals
Rabbit and rat antibodies to VAPB and PTPIP51 were as
described [9]. Rabbit anti-PTPIP51 and chicken anti-MAP 2
were from Gentex. Rabbit anti-translocase of the outer
mitochondrial membrane protein-20 (TOM20), mouse
anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
and goat anti-synaptophysin were from Santa Cruz
Biotechnology. Mouse anti-β-Tubulin Isotype III antibody
and mouse anti-β-Actin were from Sigma. Mouse anti-post
synaptic density protein-95 (PSD95) was from Millipore,
mouse anti-protein disulphide isomerase (PDI) was from
Thermo Fisher Scientific and mouse anti-phosphorylated
neurofilament heavy chain (NFH) (antibody SMI31) was
from Sternberger Monoclonals Inc. Species specific goat
and donkey anti-mouse, −rabbit and -chicken Igs coupled
to AlexaFluor-488, − 594 or − 647 were from Invitrogen,
Jackson ImmunoResearch, ThermoFisher or Abcam. FM
4–64 was from Invitrogen, DL-2-amino-5-phosphonovale-
ric acid (AP5) was from Cayman chemical company and
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) was from
Santa Cruz.
Hippocampal neuronal culture and transfection
Hippocampal neurons were obtained from embryonic
day 18 rat embryos and cultured in Neurobasal medium
containing B27 supplement, 100 IU/ml penicillin,
100 μg/ml streptomycin and 2mML-glutamine (Invitro-
gen). Neurons were cultured on poly-d-lysine-coated
glass cover slips in 12-well plates and analysed at
DIV20–23. For siRNA studies, neurons were untreated
or treated with 1 μM of each siRNA for 72 h prior to
analyses. For transfection studies, neurons were trans-
fected at DIV5 using Lipofectamine 2000 (Invitrogen)
(0.5 μg plasmid DNA, 1 μl Lipofectamine 2000 per well)
according to the manufacturer’s instructions.
Protein fractionation, SDS–PAGE and immunoblotting
Cells were harvested for sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis (SDS-PAGE) by washing
with calcium-free phosphate buffered saline (PBS)
pre-warmed at 37 °C and scraping into SDS-PAGE sam-
ple buffer containing protease inhibitors (Complete
Roche), 1 mM Na3VO4 and 5mM NaF. Samples were
then heated for 10 min at 100 °C, sonicated and centri-
fuged at 10000 g (av) for 10 min. Total, cytosolic and
synaptoneurosome proteins were prepared from rat
brains essentially as described [35, 47]. Protein concen-
trations were determined using a commercial BCA assay
(Pierce). Samples were prepared for SDS-PAGE by
addition of sample buffer and then resolved on 10 or 15%
SDS-PAGE gels and transferred to nitrocellulose mem-
branes (Schleicher & Schuell Bioscence) by wet electro-
blotting (BioRad). Membranes were blocked with
Tris-HCl-buffered saline (TBS) containing 5% dried milk
and 0.1% Tween-20 for 1 h at 20 °C, and then incubated
with primary antibodies in blocking buffer for 16 h at 4 °C.
Following washing in TBS containing 0.1% Tween-20, the
blots were incubated with horseradish peroxidase conju-
gated secondary antibodies and developed using chemilu-
minescence with a Luminata Forte Western HRP
substrate system according to the manufacturer’s
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instructions (Millipore). Chemiluminescence signals were
detected using a BioRad ChemiDoc MP Imaging system.
Immunofluorescence staining and proximity ligation assays
Neurons grown on coverslips were fixed for 15 min at
20 °C with 4% (w/v) paraformaldehyde in PBS and then
permeabilized with PBS containing 0.5% Triton X-100
for 15 min. Samples were then preincubated with block-
ing buffer (PBS containing 10% goat or 2% donkey
serum and 0.5% Triton X-100) for 1 h and incubated
with primary antibodies diluted in blocking buffer for
16 h at 4 °C. Following washing in PBS containing 0.5%
Triton X-100, the samples were incubated with goat/
donkey anti-rabbit, mouse, rat or chicken Igs coupled to
AlexaFluor − 488, − 594 or 647 in PBS for 1 h, washed in
PBS and then mounted in Vectashield mounting
medium (Vector Laboratories). Proximity ligation assays
(PLAs) to identify the VAPB-PTPIP51 interaction were
performed essentially as described previously using Duo-
link reagents (Sigma-Aldrich) [13]. Briefly, neurons were
fixed in 4% paraformaldehyde in PBS and probed with
rat anti-PTPIP51 and rabbit anti-VAPB antibodies, and
signals developed using a Duolink In Situ Orange kit
(Sigma-Aldrich). Following PLAs, neurons were immu-
nolabeled for synaptophysin and PSD95.
Microscopy
Super resolution structured illumination microscopy
(SIM) was performed using Nikon Eclipse Ti-E Inverted
microscopes with 100× 1.49 NA CFI objectives and
equipped with Nikon N-SIM or Visitech iSIM Super Reso-
lution Systems. Images were captured using an Andor
iXon EMCCD camera and reconstructed using Nikon im-
aging software Elements Advanced Research with N-SIM
module or Nikon deconvolution software for iSIM.
Live cell imaging was performed by time-lapse micros-
copy using a Nikon Eclipse Ti microscope equipped with
an Intenslight C-HGFI light source, CFI Apo Lambda S
60x/1.40 objective, TiND6 PFS-S Perfect Focus Unit and
EGFP, DsRed and EGFP/DsRed dual filter sets (Chroma
Technology). Images were captured using an Andor Neo
sCMOD camera. For dual imaging, EGFP and DsRed
signals were captured simultaneously using an EGFP/
DsRed dual filter set, an Andor TuCam camera adapter
system equipped with an emission GFP/RFP dichroic
filter set and two Andor Neo sCMOD cameras. Move-
ments were recorded using Nikon NIS-Elements AR
software at 2 or 3 s time-lapse intervals. Temperature
was maintained at 37 °C using a microscope incubation
chamber (Solent Scientific). During recordings, neurons
were kept under constant perfusion (0.5 ml/min) with
external solution using a Bio-Logic MSC200 fast perfu-
sion system. External solution comprised 140mM NaCl,
5 mM KCl, 5 mM NaHCO3, 1 mM MgCl2, 1.2 mM
CaCl2, 1.2 mM Na2HPO4, 10 mM glucose in 20mM
HEPES buffer pH 7.4.
Electrical field stimulations were performed in a Cham-
lide EC-B18 field stimulation chamber and field stimulation
(25mA pulses of 1ms duration) delivered by an Isolated
Stimulator DS3 controlled by a Train/Delay Generator
DG2A (Digitimer). Analyses involving FM 4–64 were per-
formed essentially as described [19]. Briefly, FM 4–64
(2.5 μM) was added in external solution and loaded into
neurons with electrical field stimulation (20Hz for 60 s)
which was applied with an insert adaptor in the culture
plates (RC-37FS, Warner instruments). FM 4–64 dye was
removed from the surface membranes by incubation in
external solution containing NMDA and AMPA receptor
antagonists (50 μM AP5, 10 μM CNQX) followed by incu-
bation in Ca2+-free external solution. Neurons were then
transferred to the microscope field stimulation chamber
and analysed in time-lapse. For analyses of SPLICSs, field
stimulations were delivered at frequency of 30Hz for 10 s.
For analyses of FM 4–64, 3 field stimulations of 60 s at 20
Hz were applied at 60 s intervals as described [19]. For ana-
lyses of SypHy-RGECO signals, 3 field stimulations of 10 s
at 30Hz were applied at 60 s intervals essentially as
described [20]. VAPB-PTPIP51 PLA field stimulations were
conducted in the culture plates using the insert adaptor
delivering stimulations of 30Hz for 10 s. Neurons were
then fixed and processed for PLAs and immunostaining.
Confocal microscopy images were acquired using a
Leica TCS-SP5 confocal microscope using a 63x HCX
PL APO lambda blue CS 1.4 oil UV objective. Z-stack
images were analysed and processed using Leica Applied
Systems (LAS AF6000) image acquisition software.
PLA signals were quantified in close proximity (less than
1 μm) to synaptic contacts identified by synaptophysin/
PSD95 apposition using NIH ImageJ in 20 μm segments of
dendrites after the first dendritic branchpoint. ER-mito-
chondria contacts were quantified by analyses of PDI/
TOM20 colocalization with Pearson’s coefficient using
Nikon Imaging Software Elements AR. Dendritic spine
densities were quantified using NeuronStudio software
(CNIC). Active spines involving apposition of spines to
synaptophysin signals were quantified using ImageJ in 20 μm
segments of dendrites located after the first branch.
Time-lapse movies were processed offline using the
NIS-Elements AR software and ImageJ. FM 4–64 and
SypHy-RGECO signals were quantified as described [19, 20].
Results
VAPB and PTPIP51 localise and interact at synapses
We used super resolution structured illumination mi-
croscopy (SIM) to study whether VAPB and PTPIP51 lo-
calise to synaptic regions in cultured 20–23 day in vitro
(DIV) rat hippocampal neurons; these neurons form ma-
ture functional synapses. We first stained neurons for
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synaptophysin+PSD95 and either VAPB or PTPIP51.
Synaptophysin and PSD95 are pre- and postsynaptic
markers and synaptic pairs can be identified by close
apposition (less than 0.5 μm) of these proteins [36].
These studies revealed that both VAPB and PTPIP51 lo-
calise in close proximity to synaptic pairs (Fig. 1a, b).
We then enquired whether this synaptic localisation was
near presynaptic axonal boutons and/or postsynaptic
dendritic spines. To identify VAPB and PTPIP51 in pre-
synaptic regions, neurons were immunostained for phos-
phorylated NFH to identify axons, synaptophysin and
either VAPB or PTPIP51. To identify VAPB and
PTPIP51 in postsynaptic regions, neurons were immu-
nostained for microtubule-associated protein-2 (MAP2)
to identify dendrites, PSD95 and either VAPB or
PTPIP51. These studies revealed that both VAPB and
PTPIP51 were present in close proximity to both axonal
boutons and dendritic spines (Fig. 1c, d).
To complement these studies, we prepared biochem-
ical fractions of synaptoneurosomes from rat brain and
probed these on immunoblots for VAPB and PTPIP51,
synaptophysin and PSD95 as synaptic markers, and PDI
and TOM20 as ER and mitochondrial markers. Such
synaptoneurosome preparations have been extensively
characterised and contain the presynaptic synaptosome
with attached postsynaptic neurosome [35, 47]. For these
immunoblots we also loaded equal amounts of total
mouse brain and cytosolic (soluble) proteins for com-
parison. These studies revealed that VAPB and PTPIP51
were present in synaptoneurosomes (Fig. 1e). Finally, we
performed proximity ligation assays (PLAs) to determine
whether VAPB and PTPIP51 are closely associated with
each other in synaptic regions in the cultured hippocam-
pal neurons. The distances required for PLA signals are
similar to those detected by resonance energy transfer
between fluorophores (i.e. approximately 10 nm) and so
PLAs are suitable for quantifying ER-mitochondria con-
tacts of 10–30 nm [42]. Indeed, PLAs including ones for
VAPB and PTPIP51 have already been used to quantify
ER-mitochondria contacts [9, 13, 16, 33, 46]. Synapses
were identified by close apposition of synaptophysin and
PSD95 immunofluorescent signals. These studies re-
vealed that VAPB-PTPIP51 PLA signals were closely as-
sociated with synapses (less than 1 μm distance) (Fig. 1f )
(and see Fig. 2c). Thus, VAPB and PTPIP51 localise and
interact in synaptic regions.
Synaptic activity stimulates ER-mitochondria contacts and
the VAPB-PTPIP51 interaction
The localisation and interaction of VAPB and PTPIP51
in synaptic regions suggest they play a role in synaptic
function. We therefore monitored how synaptic activity
affects ER-mitochondria contacts and the VAPB-
PTPIP51 interaction. To do so we first utilised split
green fluorescent protein (GFP) ER-mitochondria con-
tact reporter (SPLICS) plasmids that comprise outer
mitochondrial membrane and ER targeting sequences
fused respectively to the GFP1–10 and β-strand 11 of
the superfolder GFP variant [6]. This SPLICSs contact
sensor only fluoresces when the two organelles are
brought into close (approximately 10 nm) proximity so
as to restore GFP functional domains [6]. SPLICSs trans-
fected hippocampal neurons displayed fluorescence
signals in cell bodies, axons and dendrites demonstrating
close ER-mitochondria contacts in the cells (Fig. 2a).
The intensities of these SPLICSs signals displayed no notice-
able changes over extended monitoring periods (10min)
which indicates that ER-mitochondria contacts are stable in
the neurons (Fig. 2b). This observation is consistent with
previous studies of SPLICSs transfected cells which show
stable signals over many hours [6]. However, induction of
synaptic activity by electrical field stimulation [19, 20] mark-
edly increased the SPLICSs signals in cell bodies and
processes (Fig. 2c and Additional file 1: Movie 1).
To determine whether any of these increased SPLICSs
fluorescent signals were associated with active synapses,
we loaded the neurons with the red fluorescent synaptic
vesicle recycling dye FM 4–64 and monitored both FM
4–64 and SPLICSs fluorescent signals prior to and
following electrical field stimulation. During loading, FM
4–64 is taken into synaptic vesicles as they form via
endocytosis; however, during synaptic activity FM 4–64
fluorescent signals are reduced as vesicles are released
from active synapses [19]. Electrical field stimulation
induced selective decreases in FM 4–64 signals of ap-
proximately 30%; these reductions are in line with those
reported by others following similar treatments [27, 30,
48] (Fig. 2d). These decreases were accompanied by in-
creased SPLICSs fluorescence indicating increased
ER-mitochondria contacts (Fig. 2d). Notably, many of
these increased SPLICSs signals localised close to active
synapses as identified by reduction of FM 4–64 signals
(Fig. 2d and Additional file 2: Movie 2).
We also enquired whether the increases in
ER-mitochondria contacts induced by synaptic activity in the
hippocampal neurons were linked to changes in the
VAPB-PTPIP51 interaction. To do so, we performed
VAPB-PTPIP51 PLAs on unstimulated neurons and on neu-
rons following electrical field stimulation, and monitored
whether any changes in PLA signals were close to synapses.
Synapses were identified by apposition of synaptophysin and
PSD95 immunofluorescent signals. Quantification of these
PLA signals were in the same regions of unstimulated and
stimulated neurons (20 μm segments after the first dendritic
branchpoint). Electrical field stimulation increased the
numbers of VAPB-PTPIP51 PLA signals and this in-
cluded signals that were close (less than 1 μm
distance) to synapses (Fig. 2e).
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Fig. 1 (See legend on next page.)
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Loss of VAPB and PTPIP51 reduce dendritic spine numbers
and synaptic activity
The above findings suggest that the VAPB-PTPIP51 tethers
play a role in synaptic function. To test this possibility fur-
ther, we first enquired how siRNA loss of VAPB or
PTPIP51 affects dendritic spine numbers in the hippocam-
pal neurons since spine numbers are closely linked with
synapse function [21]. siRNAs for VAPB and PTPIP51
have been characterised previously [9, 13, 45] and we con-
firmed that these siRNAs reduced VAPB and PTPIP51
protein levels in the rat neurons (Fig. 3a). Individual
VAPB/PTPIP51 siRNAs were all effective as were the
mixed “pools” of these siRNAs. The pooled siRNAs led to
approximate 82% (± 9.1%) and 66% (±2.9%) reductions in
VAPB and PTPIP51 levels respectively, and were used in
all later experiments. We also confirmed that as in other
cell types, this loss of VAPB and PTPIP51 reduced
ER-mitochondria contacts in the neurons by performing
super resolution SIM on untreated, control, VAPB and
PTPIP51 siRNA treated neurons that were immunostained
for PDI and TOM20 to label ER and mitochondria re-
spectively. As predicted, loss of VAPB or PTPIP51 both re-
duced ER-mitochondria contacts in the neurons (Fig. 3b).
To determine how siRNA loss of VAPB or PTPIP51 af-
fects dendritic spine numbers, we transfected neurons
with EGFP to reveal neuronal morphology and identify
dendrites; such approaches have been used in many other
studies e.g. [8, 11, 49]. We then quantified spine numbers
in the same dendritic regions of the different treated neu-
rons (20 μm segments after the first branchpoint). Loss of
VAPB or PTPIP51 reduced spine numbers (Fig. 3c). We
also determined how loss of VAPB/PTPIP51 affected
spines that are part of active synaptic pairs by immuno-
staining the EGFP transfected neurons for synaptophysin.
Apposition of spines with synaptophysin immunolabelling
can be used to identify active spines [49]. Loss of VAPB or
PTPIP51 also reduced active spine numbers (Fig. 3d).
Since morphological changes in synapses are linked to
synaptic function, we next studied how loss of VAPB or
PTPIP51 affects synaptic activity. We first monitored re-
lease of pre-loaded FM 4–64 dye following electrical
field stimulation in control, VAPB and PTPIP51 siRNA
knockdown neurons. As shown above (Fig. 2d) and by
others [19], electrical field stimulation induced release of
FM 4–64 from synapses with concomitant decreases in
dye signals. However, siRNA knockdown of VAPB or
PTPIP51 inhibited this loss of FM 4–64 signal (Fig. 4a).
We also utilised a genetic indicator reporter plasmid
that permits imaging of both presynaptic Ca2+ influx
and vesicle exocytosis. This reporter (SypHy-RGECO)
involves fusion of the synaptic vesicle protein synapto-
physin to both a red shifted Ca2+ indicator (RGECO1)
and a GFP-based pH sensor (pHluorin). This enables
optical correlates of Ca2+ and pH changes to be simul-
taneously monitored in synaptic vesicles [20]. Due to the
fixed stoichiometry of the two probes, the ratio of the
two responses can be used to provide an optical correl-
ate of the Ca2+ dependence of vesicle release and so
provide a measure of presynaptic activity [20]. Hence,
the correct way of reporting data obtained from the
SypHy-RGECO indicator is to display the ratio of SypHy
and RGECO signals (SypHy/RGECO) [20]. SypHy-RGECO
transfected neurons displayed punctate fluorescent signals
in both channels and electrical field stimulation induced in-
creases in these signals as described by others [20] (Fig. 4b).
However, compared to control cells, the ratio of SypHy/
RGECO amplitudes of these signals were reduced in both
VAPB and PTPIP51 siRNA treated cells consistent with di-
minished presynaptic activity (Fig. 4c). Thus, loss of VAPB
and PTPIP51 reduces dendritic spine and active spine
numbers, and decreases synaptic activity following electrical
field stimulation.
Discussion
Loss of synapses and synaptic dysfunction are principal
features of the major human neurodegenerative diseases
Alzheimer’s disease, Parkinson’s disease and FTD/ALS
[3, 17, 43]. Damage to ER-mitochondria contacts and
signaling is increasingly linked to these diseases and for
Parkinson’s disease and FTD/ALS this includes disrup-
tion to the VAPB-PTPIP51 ER-mitochondria tethering
proteins [1, 23, 33, 34, 45, 46]. However, whilst ER and
mitochondria are both present in synaptic regions [16,
18, 31, 50] any role that the VAPB-PTPIP51 tethers play
in synaptic function is not currently known. Such know-
ledge is essential for determining whether disruption to
(See figure on previous page.)
Fig. 1 VAPB and PTPIP51 localise and interact at synapses. a and b Super-resolution SIM images of VAPB (a) and PTPIP51 (b) localisation close to synaptic pairs.
Hippocampal neurons were immunolabeled for synaptophysin (SYN) and PSD95, and either VAPB or PTPIP51. SYN+ PSD95 identifies synaptic contacts (arrows)
via apposition of labelling. MERGE images show VAPB or PTPIP51 staining closely localised to synaptic contacts indicated by arrows shown in SYN+PSD95.
c and d SIM images of VAPB and PTPIP51 localisation close to presynaptic (c) and postsynaptic (d) compartments. c shows presynaptic compartment identified
by immunostaining for axons with phosphorylated NFH and synaptophysin. d shows postsynaptic compartment identified by immunostaining for dendrites
with MAP2 and PSD95. Arrows in (c) and (d) MERGE indicate some VAPB and PTPIP51 labeling close to synaptophysin and PSD95. e VAPB and PTPIP51 are
present in synaptoneurosomes. Immunoblot shows equal loading (12μg) of total mouse brain protein, synaptoneurosome (SN) and soluble cytoplasmic
protein (Cyt) fractions probed for synaptophysin (SYN), PSD95, VAPB, PTPIP51, PDI (ER marker) TOM20 (mitochondrial marker) and GAPDH (cytosolic marker).
f VAPB-PTPIP51 PLA signals localise close to synapses in hippocampal neurons. PLAs were performed and the samples then immunostained for synaptophysin
(SYN) and PSD95 to identify synapses. Arrows in MERGE indicate VAPB-PTPIP51 PLA signals close to synaptic contacts. Scale bars in a-d and f = 2μm
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Fig. 2 Synaptic activity regulates ER-mitochondria contacts and the VAPB-PTPIP51 interaction in hippocampal neurons. a Confocal z-stack of neuron
transfected with SPLICSs ER-mitochondria reporter plasmids and immunostained for NFH and MAP2 to show axons and dendrites; SPLICSs fluorescent
signal is present in cell bodies axons and dendrites. Scale bar = 10 μm. b SPLICSs signals are stable in unstimulated neurons. SPLICSs transfected neuron
axons were imaged in time-lapse over a 10min period and displayed no significant changes in SPLICSs signals. Graph shows average fluorescence signal
F/initial signal F0 as a %. Error bars are SEM; N= 14 neurons from 8 different cultures. (c and d), Electrical field stimulation of synaptic activity increases ER-
mitochondria contacts including contacts close to synapses. c neurons transfected with SPLICSs ER-mitochondria reporter plasmids were imaged in time-
lapse prior to and after electrical field stimulation; image shows axon in transfected cell. d SPLICSs transfected neurons were loaded with FM 4–64 and
SPLICSs (green) and FM 4–64 (red) signals imaged in time-lapse prior to and after electrical field stimulation. Arrows indicate increased SPLICSs signals
closely associated with active synapses identified by loss of FM 4–64 signal. Graph shows changes in fluorescence signal (fluorescence at each time-point (F)/
average of all pre-stimulation frames (F0)) from 7 synapses. Error bars are SEM. Analyses of SPLICSs signal reveals no changes prior to stimulation in agreement
with data shown in (b) above but significant increases following stimulation (time 30–60 s; prior to stimulation v time 300–360; post stimulation p≤ 0.0001, one
way ANOVA with Tukey’s post hoc test). e Representative SIM image of VAPB-PTPIP51 PLA signals in synaptic regions of unstimulated neurons and in neurons
after (60 s) electrical field stimulation. VAPB-PTPIP51 PLAs (red) were performed and neurons then immunostained for synaptophysin (green) and PSD95 (blue).
Arrows indicate PLA signals close (less than 1 μm) to synapses as identified by apposition of synaptophysin and PSD95 signals. Bar chart shows normalised
VAPB-PTPIP51 PLA signals (%) close to synapses in unstimulated neurons and in neurons after electrical field stimulation. Data were analysed by Student’s t test.
N=36 neurons unstimulation and 34 neurons post stimulation from 3 independent experiments. Error bars are SEM; ***p≤ 0.001. Scale bars in c, d
and e=2μm
Gómez-Suaga et al. Acta Neuropathologica Communications            (2019) 7:35 Page 7 of 13
Fig. 3 (See legend on next page.)
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ER-mitochondria signaling and the VAPB-PTPIP51
tethers contributes to synaptic dysfunction in Parkin-
son’s disease and FTD/ALS.
Here we show that the VAPB-PTPIP51 ER-mitochondria
tethers are present and interact at synapses. We also dem-
onstrate that stimulating synaptic activity increases
ER-mitochondria contacts in synaptic regions and that this
involves increased interactions between VAPB and
PTPIP51. Finally, we show that siRNA loss of VAPB or
PTPIP51 to reduce ER-mitochondria contacts inhibits
synaptic activity including alterations to synaptic vesicle re-
lease and dendritic spine numbers. Together, our results
demonstrate that ER-mitochondria contacts mediated by
the VAPB-PTPIP51 tethers regulate synaptic function.
To determine how VAPB and PTPIP51 siRNA loss af-
fects presynaptic function, we utilised two experimental
approaches. The first involved the synaptic vesicle recyc-
ling dye FM 4–64 which is loaded into synaptic vesicles
as they form via endocytosis and then released following
induction of synaptic activity [19]. Loss of VAPB and
PTPIP51 both reduced FM 4–64 release consistent with
inhibition of presynaptic activity. The initial loading of
FM 4–64 requires stimulation of synaptic activity and so
it would be interesting in future studies to determine
whether loss of VAPB and PTPIP51 affects this process.
Such studies would assist in determining whether the
VAPB-PTPIP51 tethers affect synaptic vesicle endocyto-
sis and recycling.
The second approach utilised a genetic indicator
SypHy-RGECO that involves fusion of the synaptic
vesicle protein synaptophysin to both a red shifted
Ca2+ indicator (R-GECO1) and a GFP-based pH sen-
sor (pHluorin). Synaptic activity induces increased
Ca2+ levels and also changes in pH which are the re-
sult of release of neurotransmitter from the acidic
synaptic vesicle into the more basic synaptic cleft.
Since the pHluorin sensor is more active in basic
conditions, stimulation of synaptic activity generates
increases in both R-GECO1 and pHluorin signals.
The SypHy-RGECO indicator therefore enables optical
correlates of Ca2+ and pH changes to be simultan-
eously monitored in synaptic vesicles. As was the case
with FM 4–64 experiments, loss of VAPB and
PTPIP51 both inhibited presynaptic activity in assays
involving SypHy-RGECO.
As detailed above, following their release, synaptic ves-
icles are endocytosed for re-cycling and this involves
their re-acidification. Following stimulation of synaptic
activity, pHluorin signals initially increase with synaptic
vesicle release but then decrease as the vesicles are
endocytosed. Over the times analysed in our experi-
ments, we observed the expected increase in pHluorin
signals following induction of synaptic activity but no
marked decreases. However, the times taken for these
decreases are variable and dependent firstly upon endo-
cytosis rates and then the times taken for re-acidification
of vesicles by vATPase proton pumps. The kinetics are
also dependent upon experimental conditions such as
the strength of electrical stimulation used to induce syn-
aptic activity [38] and the type and strength of buffer
used to bathe the neurons; stronger buffers require
longer to acidify [2]. Finally, different indicator plasmids
(e.g. fusion of pHluorin to synaptophysin, synaptobrevin
and VGLUT1) can provide differences in rates of endo-
cytosis. Interestingly, like us others have shown that the
SypHy-RGECO indicator plasmid we use generates rela-
tively stable high signals following electrical field stimu-
lation [20]. Future studies that involve analyses of
SypHy-RGECO signals at later time points will help
determine how the SypHy-RGECO indicator responds
to vesicle recycling.
Aside from these presynaptic effects, we also found
that siRNA loss of VAPB and PTPIP51 decreased
total dendritic spine numbers and also the numbers
of active spines as determined by their apposition to
presynaptic synaptophysin. The VAPB-PTPIP51
(See figure on previous page.)
Fig. 3 Loss of VAPB and PTPIP51 disrupts ER-mitochondria contacts and reduces dendritic spine and active spine numbers in hippocampal neurons. a
Immunoblots showing VAPB and PTPIP51 levels in hippocampal neurons either untreated (UT) or treated with control (Ctrl), 4 different VAPB/PTPIP51 siRNAs or
a pool of these siRNAs. PTPIP51 migrates at approximately 61 kD in agreement with previous studies [9, 45]. The weakly staining upper minor species (*) on the
PTPIP51 immunoblot does not display any consistent changes in response to the PTPIP51 siRNAs and so we believe it to be non-specific protein. We did not
detect any other PTPIP51 species in the neurons. b Super resolution SIM images of neurons either untreated or treated with control, VAPB or PTPIP51 pooled
siRNAs, and then immunostained for ER and mitochondria with PDI and TOM20 antibodies. Zooms are of boxed regions with merge and co-localisation of
signals. Scale bars = 5 μm. Bar chart shows ER–mitochondria co-localisation normalized to control siRNA in the different samples. Data were analysed by one-
way ANOVA with Tukey’s post hoc test. N= 19 neurons UT, N=42 neurons Ctrl siRNA, N=42 neurons VAPB siRNA, N=40 neurons PTPIP51 siRNA from 3
independent experiments; error bars are SEM, **p≤ 0.01. c Representative images of dendritic spines in EGFP transfected neurons either untreated or treated
with control, VAPB or PTPIP51 siRNAs. Bar chart shows spine densities (spines/μm). Data were analysed by one-way ANOVA with Tukey’s post hoc test. N=14
neurons UT, N=21 neurons Ctrl siRNA, N= 17 neurons VAPB siRNA, N= 21 neurons PTPIP51 siRNA from 3 independent experiments; error bars are SEM,
*p≤ 0.05. Scale bar = 5μm. d Representative images of active dendritic spines in EGFP transfected neurons either untreated or treated with control, VAPB or
PTPIP51 siRNAs. Active spines were identified by immunostaining for the presynaptic marker synaptophysin (red) and monitoring spine and synaptophysin
apposition. Bar chart shows % of active spines normalised to control siRNA treatment. Data were analysed by one-way ANOVA with Tukey’s post hoc test.
N=19 neurons UT, N=20 neurons Ctrl siRNA, N=22 neurons VAPB siRNA, N=27 neurons PTPIP51 siRNA from 3 independent experiments; error bars are
SEM, *p≤ 0.05, **p≤ 0.01. Scale bar = 3μm
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ER-mitochondria tethers therefore have roles in both
pre- and postsynaptic function. Others have recently
shown that ER-mitochondria signaling can affect post-
synaptic function although whether this involved the
VAPB-PTPIP51 tethers was not reported [18]. Since
synapse function is intimately related to both pre-
and postsynaptic changes, these reductions in den-
dritic spine number induced by loss of VAPB and
PTPIP51 may therefore influence some of the pre-
synaptic changes we observe.
Fig. 4 Loss of VAPB or PTPIP51 disrupts synaptic activity. a Kinetics of FM 4–64 release from synaptic boutons in hippocampal neurons either
untreated (UT) or treated with control (Ctrl), VAPB or PTPIP51 siRNAs. Neurons were loaded with FM 4–64 and synaptic activity induced by electrical
field stimulation. Periods of electrical field stimulation are indicated by shaded regions. FM 4–64 signals were determined from images acquired by
time-lapse microscopy. F/F0 represents the ratio of the FM 4–64 fluorescent signals at each time point to signals at time 0. Error bars are mean ± SEM.
Bar chart shows F/F0 FM 4–64 fluorescent signals at time 330 s. Data were analysed by one-way ANOVA with Tukey’s post hoc test. N = 24 boutons UT,
N = 40 boutons Ctrl siRNA, N = 24 boutons VAPB siRNA, N = 35 boutons PTPIP51 siRNA from 3 independent experiments. Error bars are SEM, ***p≤
0.001. b Representative images of transfected SypHy-RGECO axonal signals in neurons prior to and following electrical field stimulation to induce
synaptic activity. Scale bar = 1.5 μm. Graphs show changes in SypHy (ΔG) and RGECO (ΔR) fluorescent signals; shading shows time of electrical field
stimulation. N = 18 synapses; error bars are SEM. c SypHy-RGECO reporter reveals reduced synaptic responses to electrical field stimulation in VAPB and
PTPIP51 siRNA treated hippocampal neurons. Bar-graph shows the ratio between SypHy (ΔG) and RGECO (ΔR) fluorescence signals in response to
electrical field stimulation. Data were analysed by one-way ANOVA and Tukey’s post hoc test. N = 39 synapses UT, N = 48 synapses Ctrl siRNA, N = 59
synapses VAPB siRNA, N = 41 synapses PTPIP51 siRNA from 3 to 4 independent experiments. Error bars are SEM; ***p≤ 0.001
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The precise mechanisms by which the VAPB-PTPIP51
ER-mitochondria tethers affect synaptic function are not
fully clear. However, dynamic changes in Ca2+ signaling
are fundamental to synaptic transmission. Presynaptic
Ca2+ levels regulate neurotransmitter release and den-
dritic Ca2+ alterations control synaptic plasticity [10, 40,
41, 44]. Synaptic transmission is also metabolically
expensive and ATP production to drive this transmission
is associated with mitochondrial Ca2+ levels since several
dehydrogenases in the tricarboxylic acid cycle are Ca2+
regulated [12, 14, 15, 25, 34]. A primary function of
ER-mitochondria contacts including those mediated by
the VAPB-PTPIP51 tethering proteins is to facilitate de-
livery of Ca2+ to mitochondria from ER stores [7, 9, 12,
15, 34, 45]. Indeed, the VAPB-PTPIP51 tethers have
been linked to mitochondrial ATP production [13, 33,
46]. Our findings that the VAPB-PTPIP51 tethers regu-
late synaptic function are therefore consistent with the
known roles of these proteins in Ca2+ homeostasis and
the generation of mitochondrial ATP.
Aside from these roles, ER-mitochondria contacts also
control a number of other fundamental cellular func-
tions. For example, the contacts regulate lipid metabol-
ism since the synthesis of some phospholipids involves
precursor exchange between the two organelles and the
tight contacts facilitate this exchange [7, 12, 34].
ER-mitochondria signaling involving the VAPB-PTPIP51
tethers also affects autophagosome formation [13].
Changes in lipid metabolism and autophagy are both
known to influence synaptic function [26, 32]. Thus, the
VAPB-PTPIP51 tethers may also modulate synaptic
function via their roles in these other processes.
Finally, PTPIP51 has been associated with changes in
the activities of a number of signaling molecules and in
particular, mitogen-activated protein kinase (MAP kinase)
[4]. MAP kinase plays major roles in synaptic function
[29]. In addition, and based upon its expression in differ-
ent brain regions, PTPIP51 has been linked to learning
and memory [5]. It will be interesting to determine
whether the role of PTPIP51 and VAPB in regulating
ER-mitochondria Ca2+ leads to downstream changes in
MAP kinase and other signaling molecules.
As detailed above, damage to ER-mitochondria signaling
has been associated with Alzheimer’s disease, Parkinson’s
disease and FTD/ALS and for Parkinson’s disease and
FTD/ALS this can involves disruption of the VAPB-
#PTPIP51 tethers [1, 23, 24, 33, 34, 45, 46]. Synaptic
damage is a key feature of all these diseases but the mech-
anisms underlying this damage are not fully understood.
Our findings that the VAPB-PTPIP51 tethers regulate
synaptic activity therefore provide a novel route linking
neurodegenerative disease insults with synaptic dysfunction.
Future studies to determine whether such insults affect
ER-mitochondria contacts and the VAPB-PTPIP51 tethers
in synaptic regions would provide further insight into this
topic. In addition, it will also be informative to determine
whether correction of damaged VAPB-PTPIP51 tethers
rescues synaptic damage. Interestingly, increasing
ER-mitochondria contacts via overexpression of VAPB res-
cues α-synuclein induced damage to mitochondrial Ca2+
levels [33]. Also, exogenous viral delivery of VAPB is protect-
ive in ALS mutant superoxide dismutase-1 transgenic mice
[22]. Thus, the findings we report here pave the way for
future studies that address whether synaptic damage in
neurodegenerative diseases is linked to changes in
VAPB-PTPIP51 interactions and ER-mitochondria signaling.
Conclusions
Damage to ER-mitochondria signaling is now known to
contribute to Alzheimer’s disease, Parkinson’s disease and
FTD/ALS. For Parkinson’s disease and FTD/ALS, this
damage has been shown to involve disruption to the
ER-mitochondria tethering proteins VAPB and PTPIP51
which function to recruit regions of ER to the mitochon-
drial surface. Loss of synaptic function is a key pathogenic
feature of Parkinson’s disease and FTD/ALS. Both ER and
mitochondria are present in synaptic regions but whether
ER-mitochondria signaling involving the VAPB-PTPIP51
tethers contributes to synaptic function is not known.
Here we show that the VAPB-PTPIP51 tethering proteins
are present and interact in synaptic regions and that loss
of VAPB and PTPIP51 perturbs synaptic activity. Thus,
damage to the VAPB-PTPIP51 tethers may contribute to
synaptic dysfunction in Parkinson’s disease and FTD/ALS.
Additional files
Additional file 1: Movie 1. Electrical field stimulation of synaptic activity
increases ER-mitochondria contacts. Movie shows SPLICSs fluorescent signals
in hippocampal neurons prior to and after stimulation. Time in seconds (s)
are shown. CB indicates cell body. Electrical field stimulation was applied at
30s. (MOV 10446 kb)
Additional file 2: Movie 2. Electrical field stimulation of synaptic activity
increases ER-mitochondria contacts including contacts close to synapses.
Movie shows SPLICSs signals (green) in hippocampal neuron processes
loaded with FM 4–64 (red). Arrows show increased SPLICSs signals closely
associated with active synapses identified by loss of FM 4–64 signal. Time in
seconds (s) are shown. Field stimulation was applied at 30s. (MOV 2534 kb)
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